← Back to Search

Observational for Langerhans Cell Histiocytosis

N/A
Recruiting
Led By Ronald S. Go, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* All patients diagnosed with histiocytic disorders and age ≥1 year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; post-treatment (estimated up to 2 years, potentially 4 times per year)
Awards & highlights

Study Summary

This study is being done to collect medical and personal histories as well as a samples of blood, other body fluid and/or tumor/disease tissue for current and future research studies on histiocytic disorders.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; post-treatment (estimated up to 2 years, potentially 4 times per year)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; post-treatment (estimated up to 2 years, potentially 4 times per year) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PD-L1 and T-cell Bim expression
Identify molecular markers

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients complete questionnaires and undergo blood and tissue sample collection. Patients' medical records are also reviewed.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,212 Previous Clinical Trials
3,766,538 Total Patients Enrolled
Ronald S. Go, M.D.Principal InvestigatorMayo Clinic in Rochester

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Clinical and Molecular Characteristics of Histiocytic Disorders
2017. "Clinical and Molecular Characteristics of Histiocytic Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06331377.
All > Paid Studies Minneapolis
~162 spots leftby Jul 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top